Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn

Pediatrics

Volumn 114, Issue 5, 2004, Pages 1297-1304

  Reynolds, Eric W ^a   Ellington, Jeff G ^a   Vranicar, Mark ^a   Bada, Henrietta S ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

B type natriuretic peptide; Persistent pulmonary hypertension of the newborn

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DOBUTAMINE; DOPAMINE; NITRIC OXIDE; BIOLOGICAL MARKER;

APGAR SCORE; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOASSAY; INFANT; LUNG ALVEOLUS OXYGEN TENSION; LUNG PRESSURE; MALE; MEAN ARTERIAL PRESSURE; NEWBORN DISEASE; OXYGENATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RACE DIFFERENCE; RADIODIAGNOSIS; RESPIRATORY TRACT DISEASE; TRICUSPID VALVE REGURGITATION; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; DIFFERENTIAL DIAGNOSIS; NEWBORN; PATHOPHYSIOLOGY; PERSISTENT FETUS CIRCULATION; REFERENCE VALUE; RESPIRATORY FAILURE; SENSITIVITY AND SPECIFICITY; URINE;

BIOLOGICAL MARKERS; BIRTH WEIGHT; BLOOD PRESSURE; CASE-CONTROL STUDIES; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFANT, NEWBORN; MALE; NATRIURETIC PEPTIDE, BRAIN; PERSISTENT FETAL CIRCULATION SYNDROME; REFERENCE VALUES; RESPIRATORY INSUFFICIENCY; SENSITIVITY AND SPECIFICITY; URINE;

EID: 16644387837     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-0525     Document Type: Article

References (13)

1. Yoshibayashi M, Kamiya T, Saito Y, et al. Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth. Eur J Endocrinol. 1995;133:207-209
2. Ikemoto Y, Nogi S, Teracuchi M, Kojima T, Hirata Y, Kobayashi Y. Early changes in plasma brain and atrial natriuretic peptides in premature infants: correlation with pulmonary arterial pressure. Early Hum Dev. 1996;46:55-62
3. McDowell G, Shaw C, Buchanan KD, Nicholls DP. The natriuretic peptide family. Eur J Clin Invest. 1995;25:291-298
4. Yandle T. Biochemistry of natriuretic peptides. J Intern Med. 1994;235:561-576
5. Furuhashi N, Kimura H, Nagae H, Yajima A, Kimura C, Saito T. Brain natriuretic peptide and atrial natriuretic peptide levels in normal pregnancy and preeclampsia. Gynecol Obstet Invest. 1994;38:73-77
6. Bettencourt P, Ferreira S, Azevedo A, Ferreira A. Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcome after hospital discharge in patients with heart failure. Am J Med. 2002;113:215-219
7. Maisel A. B-type natriuretic peptide levels. Cardiovasc Toxicol. 2001;1:159-164
8. Mir TS, Laux R, Hellwege HH, et al. Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates: marked and rapid increase after birth. Pediatrics. 2003;112:896-899
9. Holstrom H, Hall C, Thaulow E. Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants. Acta Paediatr. 2001;90:26-33
10. Holstrom H, Omland T, Editorial Board. Natriuretic peptides as markers of patent ductus arteriosus in preterm infants. Clin Sci (Lond). 2002;103:79-80
11. Puddy VF, Amirmansour C, Williams AF, Singer DR. Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants. Clin Sci (Lond). 2002;103:75-77
12. Daggubati S, Parks JR, Overton RM, Cintron G, Schocken DD, Vesell DL. Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators [published correction appears in Cardiovasc Res. 1999;44:452-453]. Cardiovasc Res. 1997;36:246-255
13. Hunt PJ, Yandle TG, Nichols MG, Richards AM, Espiner EA. The amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol (Oxf). 1997;47:287-296